Wellington Management Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,377
Closed -$351K 2261
2017
Q3
$351K Buy
+9,377
New +$319K ﹤0.01% 2103
2015
Q2
Sell
-170,565
Closed -$1.43M 2184
2015
Q1
$1.43M Sell
170,565
-339,949
-67% -$2.67M ﹤0.01% 1769
2014
Q4
$3.9M Sell
510,514
-416,800
-45% -$2.98M ﹤0.01% 1517
2014
Q3
$6.38M Sell
927,314
-7,300
-0.8% -$54.5K ﹤0.01% 1369
2014
Q2
$7.73M Sell
934,614
-59,300
-6% -$464K ﹤0.01% 1326
2014
Q1
$8.02M Sell
993,914
-234,856
-19% -$1.88M ﹤0.01% 1311
2013
Q4
$9.84M Sell
1,228,770
-376,600
-23% -$2.91M ﹤0.01% 1244
2013
Q3
$10.8M Buy
1,605,370
+2,000
+0.1% +$13.5K ﹤0.01% 1197
2013
Q2
$10.5M Buy
+1,603,370
New +$10.1M ﹤0.01% 1171

Other funds holding LMAT

Wellington Management Group's LMAT Position: Q4 2017 in Review

Wellington Management Group sold out of LeMaitre Vascular (LMAT) in Q4 2017, closing a stake of 9,377 shares — an estimated $351K sold.

Wellington Management Group first reported a position in LMAT in Q2 2013 and held it in 9 quarters. The position peaked at $10.8M in Q3 2013. 142 funds tracked by Wall St. Rank hold LMAT as of Q4 2017.

  • Wellington Management Group reported no remaining LeMaitre Vascular position as of Q4 2017 after selling out during the quarter.
  • Wellington Management Group sold 9,377 LeMaitre Vascular shares in Q4 2017, an estimated $351K.
  • Wellington Management Group first reported a position in LeMaitre Vascular in Q2 2013 and held it in 9 quarters.
  • Wellington Management Group's LeMaitre Vascular position peaked at $10.8M in Q3 2013.
  • 142 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2017.

Based on Wellington Management Group's 13F filing for Q4 2017, filed 13 Feb 2018.